Important News | Yinguan Bio's Participation in Drafting the Group Standard "Guidelines for Clinical Application of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Stroke" Officially Releasedby wingorSeptember 9, 2026October 23, 2026
Continued Breakthroughs | Yinguan Biotechnology's Stem Cell Drug Pipeline: A Detailed Reportby wingorSeptember 8, 2026October 23, 2026
Technological Innovation | Inglos Biotech's "Pretreated Mesenchymal Stem Cell Therapy for Stroke" Technology Submits PCT International Patent Applicationby wingorSeptember 7, 2026October 23, 2026
Good News | The "Research on Minimally Invasive Delivery Technology and Devices for Stroke Stem Cells," in which Yinguan Bio participated, is proposed to receive funding from the 2026 Shenzhen Medical Special Fund.by wingorSeptember 2, 2026October 23, 2026
News | Ingenic Biotech's latest stem cell drug IND application accepted!by wingorJune 18, 2026June 25, 2026
Event Announcement | ATMP 2026 is about to begin; Ingloun Biotech invites you to explore the forefront of cell therapy.by wingorJune 2, 2026June 3, 2026
